12 Health Care Stocks Moving In Tuesday's Intraday Session

Benzinga·04/01/2025 17:05:47

Listen to the news

Gainers

Reshape Lifesciences (NASDAQ:RSLS) stock moved upwards by 488.1% to $2.12 during Tuesday's regular session. The market value of their outstanding shares is at $7.0 million.
bioAffinity Technologies (NASDAQ:BIAF) stock increased by 236.5% to $0.87. The market value of their outstanding shares is at $13.6 million. As per the news, the Q4 earnings report came out yesterday.
Alaunos Therapeutics (NASDAQ:TCRT) shares moved upwards by 55.1% to $2.28. The market value of their outstanding shares is at $3.6 million.
Nutex Health (NASDAQ:NUTX) shares moved upwards by 53.55% to $72.22. The market value of their outstanding shares is at $392.6 million. As per the news, the Q4 earnings report came out yesterday.
Hepion Pharmaceuticals (NASDAQ:HEPA) shares moved upwards by 39.56% to $0.6.
cbdMD (AMEX:YCBD) stock moved upwards by 37.91% to $0.32. The company's market cap stands at $1.9 million.

Losers

Reviva Pharmaceuticals (NASDAQ:RVPH) shares declined by 32.3% to $0.65 during Tuesday's regular session. The market value of their outstanding shares is at $30.0 million. The company's, Q4 earnings came out yesterday.
Universe Pharmaceuticals (NASDAQ:UPC) shares decreased by 29.88% to $2.88. The market value of their outstanding shares is at $43.7 million.
CARISMA Therapeutics (NASDAQ:CARM) stock decreased by 24.23% to $0.23. The company's market cap stands at $9.8 million.
Corcept Therapeutics (NASDAQ:CORT) stock declined by 18.67% to $92.9. The company's market cap stands at $9.8 billion.
Citius Pharmaceuticals (NASDAQ:CTXR) shares decreased by 18.13% to $1.22. The market value of their outstanding shares is at $10.4 million.
Elicio Therapeutics (NASDAQ:ELTX) shares declined by 17.7% to $5.07. The company's market cap stands at $80.4 million. As per the news, the Q4 earnings report came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

FAQ

Fee Schedule Open Account Deposit & Withdrawal Trading

Terms & Conditions

Client Agreement Privacy Policy Data Disclaimer Security Tips

About Webull

About us Webull Promotions Contact information Announcements

Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hk

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.

Language

English